A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently

被引：0
|
作者：
Kazmi, Syed [1 ]
Lu, Gary [2 ]
Shah, Nina [3 ]
Bashir, Qaiser [3 ]
Parmar, Simrit
Orlowski, Robert Z. [4 ]
Shah, Jatin J. [2 ]
Hosing, Chitra M.
Popat, Uday [3 ]
Dinh, Yvonne T. [3 ]
Qureshi, Sofia [3 ]
Rondon, Gabriela [3 ]
Giralt, Sergio [3 ]
Champlin, Richard [3 ]
Qazilbash, Muzaffar H.
机构：
[1] Univ Texas MD Anderson Canc Hosp, Div Canc Med, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1778 / 1778
页数：1
相关论文
共 50 条
  • [31] High-dose Thiotepa as Consolidation Therapy With Autologous Hematopoietic Stem Cell Transplantation for High-risk Ewing Family Tumors: Single-institution Experience
    Jahnukainen, Kirsi
    Kallio, Pentti
    Koivusalo, Antti
    Saarinen-Pihkala, Ulla M.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2015, 37 (07) : 536 - 542
  • [32] High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer
    Ertz-Archambault, Natalie
    Northfelt, Donald W.
    Sonbol, Mohamad Bassam
    [J]. JAMA ONCOLOGY, 2020, 6 (08) : 1299 - 1300
  • [33] Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    Samo Zver
    Vesna Zadnik
    Peter Černelč
    Mirta Koželj
    [J]. International Journal of Hematology, 2008, 88 : 227 - 236
  • [34] Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    Zver, Samo
    Zadnik, Vesna
    Cernelc, Peter
    Kozelj, Mitra
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 227 - 236
  • [35] Autologous stem cell transplantation in patients with high-risk plasmacytoma
    Jantunen, E
    Koivunen, E
    Putkonen, M
    Siitonen, T
    Juvonen, E
    Nousiainen, T
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 74 (05) : 402 - 406
  • [36] High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma
    Bensinger, WI
    Rowley, SD
    Demirer, T
    Lilleby, K
    Schiffman, K
    Clift, RA
    Appelbaum, FR
    Fefer, A
    Barnett, T
    Storb, R
    Chauncey, T
    Maziarz, RT
    Klarnet, J
    McSweeney, P
    Holmberg, L
    Maloney, DG
    Weaver, CH
    Buckner, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1447 - 1456
  • [37] Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma
    Pasvolsky, Oren
    Milton, Denai R.
    Rauf, Mikael
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Tang, Guilin
    Saini, Neeraj
    Ramdial, Jeremy
    Masood, Adeel
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 752.e1 - 752.e6
  • [38] Autologous hematopoietic cell transplantation for high-risk ALL
    Linker, C.
    Damon, L.
    Martin, T.
    Blume, K.
    Forman, S.
    Snyder, D.
    Wolf, J.
    Negrin, R.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 (03) : 460 - 461
  • [39] Autologous hematopoietic cell transplantation for high-risk ALL
    C Linker
    L Damon
    T Martin
    K Blume
    S Forman
    D Snyder
    J Wolf
    R Negrin
    [J]. Bone Marrow Transplantation, 2011, 46 : 460 - 461
  • [40] Adoptive immunotherapy with haploidentical donor lymphocyte infusions (DLI) in the setting of high-dose therapy with autologous stem cell transplantation for high-risk multiple myeloma.
    Ballester, OF
    Raptis, A
    Jillella, A
    Hiemenz, J
    Wilcox, P
    Ballester, G
    Townsend, A
    [J]. BLOOD, 2002, 100 (11) : 408B - 408B
12345